{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:07:29Z","timestamp":1770466049390,"version":"3.49.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Limited evidence from case reports suggests that coronavirus disease 2019 (COVID-19) vaccination may interact with the treatment outcomes of psychiatric medications. Apart from clozapine, reports on the effect of COVID-19 vaccination on other psychotropic agents are scarce. This study aimed to investigate the impact of COVID-19 vaccination on the plasma levels of different psychotropic drugs using therapeutic drug monitoring.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Plasma levels of psychotropic agents, including agomelatine, amisulpride, amitriptyline, escitalopram, fluoxetine, lamotrigine, mirtazapine, olanzapine, quetiapine, sertraline, trazodone, and venlafaxine, from inpatients with a broad spectrum of psychiatric diseases receiving COVID-19 vaccinations were collected at 2 medical centers between 08\/2021 and 02\/2022 under steady-state conditions before and after vaccination. Postvaccination changes were estimated as a percentage of baseline.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Data from 16 patients who received COVID-19 vaccination were included. The largest changes in plasma levels were reported for quetiapine (+101.2%) and trazodone (\u221238.5%) in 1 and 3 patients, respectively, 1 day postvaccination compared with baseline levels. One week postvaccination, the plasma levels of fluoxetine (active moiety) and escitalopram increased by 31% and 24.9%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This study provides the first evidence of major changes in the plasma levels of escitalopram, fluoxetine, trazodone, and quetiapine after COVID-19 vaccination. When planning COVID-19 vaccination for patients treated with these medications, clinicians should monitor rapid changes in bioavailability and consider short-term dose adjustments to ensure safety.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001118","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T04:00:39Z","timestamp":1686369639000},"page":"792-796","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Changes in Psychotropic Drug Blood Levels After SARS-CoV-2 Vaccination: A Two-Center Cohort Study"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-8458","authenticated-orcid":false,"given":"Maxim","family":"Kuzin","sequence":"first","affiliation":[{"name":"Clienia Schloessli, Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich, Oetwil am See, Zurich, Switzerland;"},{"name":"Arbeitsgemeinschaft fu\u0308r Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group \u201cTherapeutic Drug Monitoring\u201d, Nu\u0308rnberg, Germany;"},{"name":"University of Nicosia Medical School, Nicosia, Cyprus;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Gardin","sequence":"additional","affiliation":[{"name":"Clienia Schloessli, Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich, Oetwil am See, Zurich, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"G\u00f6tschi","sequence":"additional","affiliation":[{"name":"Clienia Schloessli, Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich, Oetwil am See, Zurich, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziskos","family":"Xepapadakos","sequence":"additional","affiliation":[{"name":"Clienia Schloessli, Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich, Oetwil am See, Zurich, Switzerland;"},{"name":"University of Nicosia Medical School, Nicosia, Cyprus;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfram","family":"Kawohl","sequence":"additional","affiliation":[{"name":"Clienia Schloessli, Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich, Oetwil am See, Zurich, Switzerland;"},{"name":"University of Nicosia Medical School, Nicosia, Cyprus;"},{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich","family":"Seifritz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Trauzeddel","sequence":"additional","affiliation":[{"name":"Alexianer Hospital Aachen, Aachen, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Paulzen","sequence":"additional","affiliation":[{"name":"Arbeitsgemeinschaft fu\u0308r Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group \u201cTherapeutic Drug Monitoring\u201d, Nu\u0308rnberg, Germany;"},{"name":"Alexianer Hospital Aachen, Aachen, Germany;"},{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, and JARA\u2014Translational Brain Medicine, Aachen, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[{"name":"Arbeitsgemeinschaft fu\u0308r Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)-Work Group \u201cTherapeutic Drug Monitoring\u201d, Nu\u0308rnberg, Germany;"},{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland;"},{"name":"Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, New York, New York; and"},{"name":"Department of Psychiatry, Zucker School of Medicine at Northwell\/Hofstra, Hempstead, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(21)02867-1","article-title":"Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamapsychiatry.2020.4396","article-title":"Maximizing the uptake of a COVID-19 vaccine in people with severe mental illness: a public health priority","volume":"78","author":"Warren","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","article-title":"Psychotropic medicine consumption in 65 countries and regions 2008-19: a longitudinal study","volume":"8","author":"Brauer","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"010341","DOI":"10.7189\/jogh.10.010341","article-title":"A classification of the aims of vaccination and its relevance to transgenerational justice","volume":"10","author":"Atzinger","year":"2020","journal-title":"J Glob Health"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat Immunol"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"733935","DOI":"10.3389\/fphar.2021.733935","article-title":"Influence of inflammation on cytochromes P450 activity in adults: a systematic review of the literature","volume":"12","author":"Lenoir","year":"2021","journal-title":"Front Pharmacol"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40264-015-0330-8","article-title":"Vaccine-drug interactions: cytokines, cytochromes, and molecular mechanisms","volume":"38","author":"Pellegrino","year":"2015","journal-title":"Drug Saf"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/dmd.120.000261","article-title":"Functional characterization of 40 CYP3A4 variants by assessing midazolam 1\u2032-hydroxylation and testosterone 6\u03b2-hydroxylation","volume":"49","author":"Kumondai","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/pgs-2017-0033","article-title":"Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing","volume":"18","author":"Yang","year":"2017","journal-title":"Pharmacogenomics"},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/cpt.2412","article-title":"Impact of SARS-CoV-2 infection (COVID-19) on cytochromes P450 activity assessed by the Geneva cocktail","volume":"110","author":"Lenoir","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"e100183","DOI":"10.1136\/gpsych-2019-100183","article-title":"Clozapine is strongly associated with the risk of pneumonia and inflammation","volume":"33","author":"De Leon","year":"2020","journal-title":"Gen Psychiatry"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/JCP.0000000000001207","article-title":"Changes in clozapine bioavailability in a percutaneous endoscopic gastrostomy-fed patient with treatment-resistant schizophrenia","volume":"40","author":"Kuzin","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"107627","DOI":"10.1016\/j.pharmthera.2020.107627","article-title":"Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment","volume":"215","author":"Stanke-Labesque","year":"2020","journal-title":"Pharmacol Ther"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1176\/appi.ajp.2020.20071039","article-title":"Clozapine intoxication in COVID-19","volume":"178","author":"Tio","year":"2021","journal-title":"Am J Psychiatry"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"E210","DOI":"10.1503\/jpn.210027","article-title":"Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination","volume":"46","author":"Thompson","year":"2021","journal-title":"J Psychiatry Neurosci"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/schbul\/sbaa070","article-title":"COVID-19 infection may cause clozapine intoxication: case report and discussion","volume":"46","author":"Cranshaw","year":"2020","journal-title":"Schizophrenia Bull"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/JCP.0000000000001522","article-title":"Elevated clozapine blood concentrations after second COVID-19 vaccination with Spikevax (COVID-19 vaccine moderna)","volume":"42","author":"Knochel","year":"2022","journal-title":"J Clin Psychopharmacol"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.200061","article-title":"Consensus statement on the use of clozapine during the COVID-19 pandemic","volume":"45","author":"Siskind","year":"2020","journal-title":"J Psychiatry Neurosci"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s002280100375","article-title":"Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia","volume":"57","author":"Raaska","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"R22-20250603","article-title":"Behind the curtain: therapeutic drug monitoring of psychotropic drugs from a laboratory analytical perspective","author":"Scherf-Clavel","year":"2023","journal-title":"Ther Drug Monit"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/pharmaceutics13101544","article-title":"Inflammation induces changes in the functional expression of P-gp, BCRP, and MRP2: an overview of different models and consequences for drug disposition","volume":"13","author":"Saib","year":"2021","journal-title":"Pharmaceutics"},{"key":"R24-20250603","article-title":"Asian adult patients may need lower olanzapine doses. A systematic review of the literature and a comparison between Chinese and European samples after stratification","author":"Ruan","year":"2023","journal-title":"Ther Drug Monitor"},{"key":"R25-20250603","article-title":"Menstrual cycle associated changes in psychotropic drug levels: a pilot study","author":"Spadi","year":"2023","journal-title":"Ther Drug Monitor"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:12:36Z","timestamp":1748970756000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001118","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"2023-02-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}